Literature DB >> 22766733

Lowered serum amyloid-β1-42 autoantibodies in individuals with lifetime depression.

Walter Maetzler1, Markus Langkamp, Stefanie Lerche, Jana Godau, Kathrin Brockmann, Alexandra Gaenslen, Heiko Huber, Isabel Wurster, Raphael Niebler, Gerhard W Eschweiler, Daniela Berg.   

Abstract

Reduced levels of naturally occurring autoantibodies against amyloid-β (Aβ) have been described in Alzheimer's disease (AD). Lifetime depression doubles the risk of AD, thus these autoantibodies may also be reduced in this group. We measured serum IgG autoantibody titers against Aβ1-42, S100b and α-synuclein in 214 individuals with depression and 419 controls. Titers against Aβ1-42 were lower in individuals with lifetime depression (5544.6 ± 389.3) compared to controls (7208.7 ± 482.4; p = 0.048). Titers against S100b and α-synuclein were comparable between the cohorts. These data suggest an AD-like impairment of the humoral immune response in a relevant proportion of individuals with depression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766733     DOI: 10.3233/JAD-2012-120625

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.

Authors:  William D Brubaker; Andrés Crane; Jenny U Johansson; Kevin Yen; Kristina Garfinkel; Diego Mastroeni; Priya Asok; Bonnie Bradt; Marwan Sabbagh; Tanya L Wallace; Courtney Glavis-Bloom; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-05-02       Impact factor: 21.566

2.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

3.  Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency.

Authors:  Sebastian Heinzel; Florian G Metzger; Ann-Christine Ehlis; Robert Korell; Ahmed Alboji; Florian B Haeussinger; Isabel Wurster; Kathrin Brockmann; Ulrike Suenkel; Gerhard W Eschweiler; Walter Maetzler; Daniela Berg; Andreas J Fallgatter
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

4.  Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.

Authors:  Michela Deleidi; Walter Maetzler
Journal:  Int J Alzheimers Dis       Date:  2012-10-22

5.  Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.

Authors:  Walter Maetzler; Anja Apel; Markus Langkamp; Christian Deuschle; Sarah Selina Dilger; Johannes Georg Stirnkorb; Claudia Schulte; Erwin Schleicher; Thomas Gasser; Daniela Berg
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

6.  A neurodegenerative vascular burden index and the impact on cognition.

Authors:  Sebastian Heinzel; Inga Liepelt-Scarfone; Benjamin Roeben; Isabella Nasi-Kordhishti; Ulrike Suenkel; Isabel Wurster; Kathrin Brockmann; Andreas Fritsche; Raphael Niebler; Florian G Metzger; Gerhard W Eschweiler; Andreas J Fallgatter; Walter Maetzler; Daniela Berg
Journal:  Front Aging Neurosci       Date:  2014-07-09       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.